Candriam Equities L Oncology Impact I
LU1864482358
Candriam Equities L Oncology Impact I/ LU1864482358 /
NAV 23.05.2024
Diff.-25,1201
Ertragstyp
Ausrichtung
Fondsgesellschaft
2.851,1899 USD
-0,87%
thesaurierend
Aktien
weltweit
Candriam ▶
Kennzahlen und Performance in:
Alle Kurse in USD
Tranchen
Titel
Ertragstyp
Rückn. Preis
1 Jahr
3 Jahre
Candriam Equities L Oncology Imp...
thesaurierend
2.373,6201
+5,87%
+4,61%
Candriam Equities L Oncology Imp...
thesaurierend
2.536,3999
+6,01%
+5,00%
Candriam Equities L Oncology Imp...
thesaurierend
205,5000
+2,36%
-6,17%
Candriam Equities L Oncology Imp...
thesaurierend
2.219,1599
+3,13%
+15,22%
Candriam Equities L Oncology Imp...
ausschüttend
1.592,9000
+5,53%
+3,61%
Candriam Equities L Oncology Imp...
thesaurierend
243,5800
+4,08%
+13,92%
Candriam Equities L Oncology Imp...
ausschüttend
233,5500
+4,54%
+0,75%
Candriam Equities L Oncology Imp...
ausschüttend
189,1400
+5,44%
+3,31%
Candriam Equities L Oncology Imp...
ausschüttend
20.588,0000
+1,43%
+1,24%
Candriam Equities L Oncology Imp...
thesaurierend
157,0000
+3,01%
+14,83%
Candriam Equities L Oncology Imp...
thesaurierend
2.089,5901
+3,32%
-3,48%
Candriam Equities L Oncology Imp...
thesaurierend
258,1100
+4,96%
+16,83%
Candriam Equities L Oncology Imp...
thesaurierend
204,9800
+1,94%
-7,27%
Candriam Equities L Oncology Imp...
thesaurierend
283,6000
+5,42%
+3,29%
Candriam Equities L Oncology Imp...
thesaurierend
191,9200
+3,21%
-
Candriam Equities L Oncology Imp...
thesaurierend
1.830,5000
+3,46%
-
Candriam Equities L Oncology Imp...
thesaurierend
2.851,1899
+5,53%
+3,61%
Candriam Equities L Oncology Imp...
thesaurierend
156,5900
-
-
Candriam Equities L Oncology Imp...
thesaurierend
271,3500
+4,54%
+0,73%
Performance
lfd. Jahr
+7,45%
6 Monate
+15,19%
1 Jahr
+5,53%
3 Jahre
+3,61%
5 Jahre
+64,12%
10 Jahre
-
seit Beginn
+90,08%
Jahr
2023
+1,11%
2022
-9,67%
2021
+3,43%
2020
+32,43%
2019
+41,52%